About This 510(k) Submission
K251463 is an FDA 510(k) clearance for the EnSite? X EP System, AutoMark Index Software License (ENSITE-AMI-01); EnSite? X EP System, AutoMark Index Temporary Software License (ENSITE-D-AMI-01), a Computer, Diagnostic, Programmable (Class II — Special Controls, product code DQK), submitted by Abbott Medical (St. Paul, US). The FDA issued a Cleared decision on September 4, 2025, 115 days after receiving the submission on May 12, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1425.